Ulrich R, Meisel H, Schütt M, Schmidt J, Kunz A, Klempa B, Niedrig M, Pauli G, Krüger D H, Koch J
Campus Mitte, Charité, Berlin.
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2004 Jul;47(7):661-70. doi: 10.1007/s00103-004-0858-8.
Hantaviruses belong to the group of "emerging" viruses. Pathogenic European hantaviruses can cause a human disease designated "hemorrhagic fever with renal syndrome" of varying severity. In general, diagnostics of hantavirus infections are based on immunofluorescence assays using virus-infected cells or enzyme immunoassays and Western blot tests using recombinant nucleocapsid proteins. For highly sensitive detection of hantavirus-specific antibodies in the enzyme immunoassay, a homologous hantavirus nucleocapsid protein is needed as a diagnostic antigen. Serological typing of hantavirus infections can be obtained by neutralization assays, which in certain cases require the use of late convalescent sera. The seroprevalence in the normal German population is about 1%. In professionally exposed risk groups, e. g., forest workers, a seroprevalence higher than that in the normal population was observed. Endemic regions for hantavirus infections are located mainly in Baden-Württemberg. In the years 2001-2003 an annual number of about 200 clinically apparent hantavirus infections were registered in Germany. Neutralization assays detected almost exclusively human infections caused by Puumala and Dobrava viruses, only very rarely by Tula virus. Until this day in Germany mainly mild to moderate courses of human hantavirus infections have been documented. Besides infections caused by "German" hantaviruses, up to 10% of the clinically apparent hantavirus infections registered annually in Germany are caused by infections imported from other countries, mainly from Europe. So far only very limited molecular genetic data about the circulating hantaviruses in Germany are available. Additional investigations are needed to get a more precise picture about the distribution of hantaviruses in Germany and to calculate the resulting risk for the human population.
汉坦病毒属于“新兴”病毒类别。致病性欧洲汉坦病毒可引发一种被称为“肾综合征出血热”的人类疾病,其严重程度各异。一般而言,汉坦病毒感染的诊断基于使用病毒感染细胞的免疫荧光测定法,或使用重组核衣壳蛋白的酶免疫测定法和蛋白质印迹试验。为了在酶免疫测定中高灵敏度地检测汉坦病毒特异性抗体,需要同源汉坦病毒核衣壳蛋白作为诊断抗原。汉坦病毒感染的血清学分型可通过中和试验获得,在某些情况下这需要使用恢复期晚期血清。德国正常人群中的血清阳性率约为1%。在职业暴露风险群体中,例如林业工人,观察到其血清阳性率高于正常人群。汉坦病毒感染的流行地区主要位于巴登-符腾堡州。在2001年至2003年期间,德国每年登记约200例有临床症状的汉坦病毒感染病例。中和试验几乎仅检测到由普马拉病毒和多布拉瓦病毒引起的人类感染,极少由图拉病毒引起。直到如今,德国记录的人类汉坦病毒感染主要为轻度至中度病程。除了由“德国”汉坦病毒引起的感染外,德国每年登记的有临床症状的汉坦病毒感染中,高达10%是由从其他国家,主要是欧洲输入的感染所致。到目前为止,关于德国境内传播的汉坦病毒的分子遗传学数据非常有限。需要进行更多调查,以更准确地了解汉坦病毒在德国的分布情况,并计算由此给人群带来的风险。